YOLANDA WALLER: Open Payments
NPI 1497115463 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 69 payments from 34 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,712
Food & beverage: $1,712
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $276 |
| Janssen Biotech, Inc. | 5 | $207 |
| Exelixis Inc. | 2 | $142 |
| Celgene Corporation | 4 | $112 |
| Daiichi Sankyo Inc. | 4 | $96 |
| GENZYME CORPORATION | 3 | $73 |
| BeOne Medicines USA, Inc. | 3 | $63 |
| Gilead Sciences, Inc. | 3 | $56 |
| KYOWA KIRIN, INC. | 3 | $55 |
| SOBI, INC | 2 | $52 |
Products named: ENHERTU, CABOMETYX, RYBREVANT, REBLOZYL, IMFINZI, TEVIMBRA, Trodelvy, POTELIGEO.
Industry payments across TN — which companies pay providers there.
